E

Enlivex Therapeutics Ltd

D

ENLV

USD

-0.07

(-4.5161%)

Market Closed

9,363.00

حجم التداول

-0.7

الربح لكل سهم

-

العائد الربحي

-1.254237

P/E

31,680,925.88

حجم السوق

اليوم

-4.5161%

1 اسبوع

-5.128%

1 شهر

17.460%

6 اشهر

-63.636%

12 اشهر

-20.000%

بداية السنة

-45.185%

كل الوقت

0%

أصول ذات صلة

Title:
Enlivex Therapeutics Ltd

Sector:

Healthcare

Industry:

Biotechnology

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا